Skip to main content
Cameron Herr, DO, Endocrinology, Kansas City, MO, Saint Luke's North Hospital - Barry Road

CameronCody LynnHerrDOMBA

Endocrinology • Kansas City, MO

Diabetes, Lipid Metabolism, Obesity, Thyroid

Endocrinologist

Join to view full profile

Dr. Herr is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Herr's full profile

Already have an account?

Education & Training

  • University of Missouri-Columbia
    University of Missouri-ColumbiaFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
  • University of Missouri-Columbia
    University of Missouri-ColumbiaResidency, Internal Medicine, 2012 - 2015
  • Rockhurst University Helzberg School of Mgmt
    Rockhurst University Helzberg School of MgmtMBA, 2012 - 2015
  • Kansas City University of Medicine and Biosciences College of Osteopathic Medicine
    Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2012
  • Rockhurst University
    Rockhurst UniversityMBA, Healthcare, 2012
  • Central College
    Central CollegeB.A., Chemistry and Spanish, with Honors, 2007

Certifications & Licensure

  • MO State Medical License
    MO State License 2015 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

Abstracts/Posters

  • Rare Family Study of Albright's Hereditary Osteodystrophy (Pseudohypoparathyroidism) in Multiple Male Members.
    Cabandugama, P., Herr, C., Harbuz-Miller, I., Gardner, M., Klachko, D, AACE Poster, University of Missouri at Columbia, Division of Endocrinology, 1/1/2017

Press Mentions

  • The Other Epidemic: Branford Woman Seeks to Raise Awareness of Fentanyl After Death of Nephew
    The Other Epidemic: Branford Woman Seeks to Raise Awareness of Fentanyl After Death of NephewSeptember 7th, 2021
  • New Haven Celebrates International Overdose Awareness Day
    New Haven Celebrates International Overdose Awareness DayAugust 31st, 2021

Research History

  • Co-InvestigatorBayer - FIDELIO and FIGARO. Sub-Investigator. Randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven, phase III study to investigate efficacy and safety of finerenone on reduction of cardiovascular morbidity and mortality.2015 - 2017

Professional Memberships

Hospital Affiliations

Dr. Cameron Herr, Dr. Cameron Herr, DO, Dr. C Herr, Dr. Cameron Cody Lynn Herr